Health economic evaluation of treatment strategies with biologic agents for rheumatoid arthritis

• Project/Area Number: 23790585
• Research Category: Grant-in-Aid for Young Scientists (B)
• Allocation Type: Multi-year Fund
• Research Field: Medical sociology
• Research Institution: Niigata University of Health and Welfare
• Principal Investigator: MORIWAKI KENSUKE 新潟医療福祉大学, 公私立大学の部局等, 講師 (10514862)
• Project Period (FY): 2011 – 2013
• Project Status: Completed (Fiscal Year 2013)
• Budget Amount: ¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000); Fiscal Year 2013: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000); Fiscal Year 2012: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000); Fiscal Year 2011: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
• Keywords: 医療経済学 / 国内研究

Research Abstract

In view of health economic evaluations of rheumatoid arthritis in Japan, following studies were conducted: (1) A model structure which reflects clinical practice in Japan was considered through a systematic review of published articles. Also availability of data for the estimation of model parameter such as QOL, cost, and clinical efficacy was examined. (2) Based on data derived from a cross sectional survey, the relation between RA disease activity and QOL or cost were analyzed. Also mapping models used for health economic evaluation were developed.

Research Products

• [Presentation] Predicting EQ-5D Utility Scores from SF-36 Scores in Patients with Rheumatoid Arthritis in Japan (2013)
  • Author(s): Moriwaki K, Ito S, Kobayashi D, Noto S, Yanagisawa S, Toujou T, Murasawa A
  • Organizer: ISPOR 16th Annual European Congress
  • Place of Presentation: Dublin, Ireland
• [Presentation] 関節リウマチ治療の医療経済評価のための基盤データの構築-疾患活動性と健康関連QOLに関する探索的解析- (2013)
  • Author(s): 森脇健介,伊藤聡,小林大介,能登真一,村澤章,東條猛
  • Organizer: 第25回中部リウマチ学会
  • Place of Presentation: 金沢
• [Presentation] Predicting EQ-5D Utility Scores from SF-36 Scores in Patients with Rheumatoid Arthritis in Japan (2013)
  • Author(s): Moriwaki K. Ito S. Kobayashi D., Noto S., Yanagisawa S., Toujou T., Murasawa A.
  • Organizer: International society for pharmacoeconomics and outcome research 16th Annual European Congress.
  • Place of Presentation: Dublin, Ireland
• [Presentation] 関節リウマチ治療の医療経済評価のための基盤データの構築 －疾患活動性と健康関連QOLに関する探索的解析－ (2013)
  • Author(s): 森脇健介, 伊藤 聡, 小林 大介, 能登 真一, 村澤 章, 東條 猛
  • Organizer: 第25回 中部リウマチ学会
  • Place of Presentation: 金沢
• [Presentation] Development and validation of a health economic model for corticosteroid-induced osteoporosis in postmenopausal women with rheumatoid arthritis in Japan (2012)
  • Author(s): Moriwaki K, Noto S, Yanagisawa S, Ito S, Toujo T
  • Organizer: ISPOR 5th Asia-Pacific Conference
  • Place of Presentation: Taipei, Taiwan
• [Presentation] Cost-effectiveness of alendronate therapy for corticosteroid-induced osteoporosis in postmenopausal women with rheumatoid arthritis in Japan (2012)
  • Author(s): Moriwaki K, Noto S, Yanagisawa S, Inoue H
  • Organizer: ISPOR 15th Annual European Congress
  • Place of Presentation: Berlin, Germany
• [Presentation] Development and validation of a health economic model for corticosteroid-induced osteoporosis in postmenopausal women with rheumatoid arthritis in Japan. (2012)
  • Author(s): Moriwaki K, Noto S, Yanagisawa S, Ito S, Toujo T
  • Organizer: ISPOR 5th Asia-Pacific Conference
  • Place of Presentation: Taipei, Taiwan